Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Gains from Investment Securities (2019 - 2025)

AdaptHealth (AHCO) has 7 years of Gains from Investment Securities data on record, last reported at $13.9 million in Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 259.0% year-over-year to $13.9 million; the TTM value through Dec 2025 reached $32.6 million, up 402.64%, while the annual FY2025 figure was $37.9 million, 1733.11% up from the prior year.
  • Gains from Investment Securities reached $13.9 million in Q4 2025 per AHCO's latest filing, down from $21.9 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $21.9 million in Q3 2025 and bottomed at -$37.5 million in Q2 2021.
  • Average Gains from Investment Securities over 5 years is $923742.1, with a median of $607695.0 recorded in 2021.
  • Peak YoY movement for Gains from Investment Securities: crashed 48182.06% in 2021, then skyrocketed 8818.18% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at $14.0 million in 2021, then increased by 1.22% to $14.2 million in 2022, then crashed by 89.29% to $1.5 million in 2023, then skyrocketed by 155.01% to $3.9 million in 2024, then skyrocketed by 259.0% to $13.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $13.9 million in Q4 2025, $21.9 million in Q3 2025, and $3.9 million in Q4 2024.